David A Pearlman
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2021First federal award
$3.8MFederal grants as PI7 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
7 awards · $3.8M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 1, 2026 | NIH | SBIR Phase II Binding free energy predictions for peptide drugs: A novel machine learning-based peptide simulation model for high-throughput computational lead optimization with quantum mechanical accuracy. | $1.0M | Quantum Simulation Technologies, Inc. |
| Jul 30, 2025 | NIH | SBIR Phase II Next generation free energy perturbation (FEP) calculations--enabled by a novel integration of quantum mechanics (QM) with molecular dynamics allowing a large QM region and no sampling compromises | $994K | Quantum Simulation Technologies, Inc. |
| Sep 3, 2024 | NIH | SBIR Phase II Next generation free energy perturbation (FEP) calculations--enabled by a novel integration of quantum mechanics (QM) with molecular dynamics allowing a large QM region and no sampling compromises | $1.0M | Quantum Simulation Technologies, Inc. |
| Sep 13, 2023 | NIH | SBIR Phase I Improved optimization of covalent ligands using a novel implementation of quantum mechanics suitable for large ligand/protein systems. | $149K | Quantum Simulation Technologies, Inc. |
| Aug 25, 2023 | NIH | SBIR Phase I Absolute binding free energies for virtual screening: A novel implementation of quantum mechanics/molecular mechanics (QM/MM) for FEP that allows substantial sampling and a significant quantum region | $273K | Quantum Simulation Technologies, Inc. |
| Mar 15, 2023 | NIH | SBIR Phase I Next generation free energy perturbation (FEP) calculations--enabled by a novel integration of quantum mechanics (QM) with molecular dynamics allowing a large QM region and no sampling compromises | $149K | Quantum Simulation Technologies, Inc. |
| Mar 1, 2021 | NIH | SBIR Phase I Scoring ligand/protein interactions using a novel high performance implementation of DFT quantum mechanics | $147K | Quantum Simulation Technologies, Inc. |
Peer ranks
Federal funding#433
Awards as PI#250
Patents#273
Companies
- Quantum Simulation Technologies, Inc.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.